A (127) | B (8) | C (26) | D (12) | E (21) | F (6) | G (1) | H (10) | I (19) | L (8) | M (7) | N (3) | O (8) | P (15) | R (29) | S (35) | T (1) | U (5) | V (14)
Title Author Last update
A 24-Week Study of the Efficacy and Safety of BLU-5937 (Camlipixant) in Adults With Refractory Chronic Cough (CALM-2) admin
A 24-Week Study of the Efficacy and Safety of BLU-5937 (Camlipixant) in Adults With Refractory Chronic Cough (CALM-2) roman
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2) admin
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2) roman
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-1) admin
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-1) admin
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic admin
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic admin
A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma ben
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants ben
A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants roman
A Phase 2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of AFX3772 Vaccine in Healthy Infants admin
A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study With Open-Label Extension of BLU-5937 (Camlipixant) in Adult Participants With Refractory Chronic Cough, Including Unexplained Chronic Cough roman
A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study With Open-Label Extension of BLU-5937 in Adult Participants With Refractory Chronic Cough, Including Unexplained Chronic Cough roman
A Phase 4, 52-week (Primary Analysis at 24-weeks), Randomized, Stratified, Open-label, Active-controlled, Parallel-group, Effectiveness Study, Comparing FF/UMEC/VI With Non-ellipta Usual Care (ICS/LABA) in Adult Participants With Uncontrolled Asthma roman
A Phase 4, 52-week (Primary Analysis at 24-weeks), Randomized, Stratified, Open-label, Active-controlled, Parallel-group, Effectiveness Study, Comparing FF/UMEC/VI With Non-ellipta Usual Care (ICS/LABA) in Adult Participants With Uncontrolled Asthma roman
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/ Metastatic Non- Small-Cell Lung Cancer admin
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) (BE-EARLY) admin
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) (BE-EARLY) ben
A Study for GSK3862995B (anti-IL33) in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease ben
A Study for GSK3862995B (anti-IL33) in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease ben
A Study for the Effect of Mepolizumab in Participants with Chronic Rhinosinusitis with Nasal Polyps and Asthma ben
A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis) (SIS) admin
A Study of an Investigational Flu Seasonal/​SARS-CoV-2 Combination Vaccine in Adults roman
A Study of an Investigational Flu Seasonal/​SARS-CoV-2 Combination Vaccine in Adults roman
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype (NIMBLE) admin
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype (NIMBLE) admin
A Study of GSK4527363 in Healthy Participants, Participants with Active Systemic Lupus Erythematosus (SLE), and Healthy Participants of Chinese and Japanese Descent ben
A Study of GSK4527363 in Healthy Participants, Participants with Active Systemic Lupus Erythematosus (SLE), and Healthy Participants of Chinese and Japanese Descent ben
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants ben
A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem- cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) (PIVOT-PO) admin
A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults admin
A Study of Sequential Therapy With Daplusiran/​Tomligisiran (DAP/​TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) (B-UNITED) ben
A Study of Sequential Therapy With Daplusiran/​Tomligisiran (DAP/​TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) (B-UNITED) ben
A Study of Sequential Therapy With Daplusiran/​Tomligisiran (DAP/​TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) (B-UNITED) admin
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease (BEconneCTD-ILD) admin